As of November 6, 2026, 2 holders' latest Schedule 13D or 13G filings report owning 5% or more of Nexalin Technology, Inc. The largest reported stake is Alumni Capital LP's, at 9.99%. 2 filings are on record since August 27, 2026 (Schedule 13G, August 27, 2026).
Sell to companies like Nexalin Technology, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Nexalin Technology, Inc. has 2 Schedule 13D or 13G filings on record since 2026-08-27. 2 holders' latest filing reports 5% or more of common stock, par value $0.001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Alumni Capital LP | 9.99% | 2,493,075 | SCHEDULE 13G, 2026-08-27 | 2026-08-19 |
| Greenlight Ventures, LLC | 5.6% | 1,385,246 | SCHEDULE 13D, 2026-09-03 | 2026-08-18 |
Holding shares or following this stake? See who's behind Nexalin Technology, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Nexalin Technology, Inc. and the records around it.
Nexalin Technology, Inc. elsewhere on the record
Companies that share a holder
- Alumni Capital LP also filed stake reports on 12 other companies: reAlpha Tech Corp. (Nov 2026), Sports Entertainment Gaming Global Corp (Nov 2026), INVO Fertility, Inc. (Aug 2026)
Watch Nexalin Technology, Inc.
Get an email when Nexalin Technology, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Nexalin Technology, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Nexalin Technology, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Nexalin Technology, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
3 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Alumni Capital LP | 0 | 2,493,075 | 0 | 2,493,075 | SCHEDULE 13G, 2026-08-27 |
| Alumni Capital GP LLC | 0 | 2,493,075 | 0 | 2,493,075 | SCHEDULE 13G, 2026-08-27 |
| Ashkan Mapar | 0 | 2,493,075 | 0 | 2,493,075 | SCHEDULE 13G, 2026-08-27 |
| Greenlight Ventures, LLC | 1,385,246 | 0 | 1,385,246 | 0 | SCHEDULE 13D, 2026-09-03 |
The latest filing identifies Nexalin Technology, Inc. by CUSIP 65345B300 and gives its principal executive office as 1776 YORKTOWN, SUITE 550, HOUSTON, TX 77056 (SCHEDULE 13D, 2026-09-03).
Source of funds (Item 3)
No funds were used to acquire the shares of Common Stock reported in this Statement. The Reporting Person acquired those shares as non-cash consideration for the sale of PONM to the Issuer. On May 14, 2026, GLV and the Issuer entered into a Stock Purchase Agreement (the "Purchase Agreement") pursuant to which the Issuer purchased from GLV 100 shares of common stock, no par value, of PONM, representing all of the issued and outstanding shares of PONM.Greenlight Ventures, LLC, SCHEDULE 13D, 2026-09-03
Purpose of Transaction (Item 4)
Greenlight Ventures, LLC
The Reporting Person acquired the Consideration Shares as consideration for the sale of PONM to the Issuer pursuant to the Purchase Agreement described in Item 3, and not by purchase for cash in the open market or otherwise. GLV and the Issuer are also parties to a Collaboration Agreement dated May 14, 2026 (the "Collaboration Agreement"), under which GLV provides the Issuer with operational, technical and strategic support relating to the continued development, compliance and commercialization of the Issuer's cranial electrotherapy stimulation technologies, in exchange for a fee of $10,000 per month over an initial term of 24 months. GLV entered into the Collaboration Agreement in its capacity as a service provider and technology counterparty. Dr. David Owens, a member of the Issuer's board of directors and the Issuer's Chief Medical Officer, holds a minority ownership interest in GLV. GLV has no right under the Purchase Agreement, the Collaboration Agreement or otherwise to designate or nominate any member of the Issuer's board of directors. The Reporting Person intends to review its investment in the Issuer on a continuing basis and may, from time to time and at any time, depending on market conditions, the Issuer's business, financial condition and prospects, the Reporting Person's own liquidity and investment considerations, and other factors the Reporting Person deems relevant, acquire additional shares of Common Stock or other securities of the Issuer, or dispose …The first part of Item 4 of the SCHEDULE 13D filed 2026-09-03; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-08-27 | Alumni Capital LP | 9.99% | SCHEDULE 13G |
| 2026-09-03 | Greenlight Ventures, LLC | 5.6% | SCHEDULE 13D |
Questions about who owns Nexalin Technology, Inc.
Who owns Nexalin Technology, Inc.?
On this page, 2 holders' latest ownership filings report 5% or more of Nexalin Technology, Inc.: Alumni Capital LP (9.99%, Schedule 13G, filed 2026-08-27) and Greenlight Ventures, LLC (5.6%, Schedule 13D, filed 2026-09-03).
Who are the largest shareholders of Nexalin Technology, Inc.?
By the share each holder's latest filing reports, the largest holders of Nexalin Technology, Inc. on this page are Alumni Capital LP (9.99%) and Greenlight Ventures, LLC (5.6%).
When did Alumni Capital LP buy into Nexalin Technology, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Alumni Capital LP on this page is the Schedule 13G, filed 2026-08-27, reporting 9.99%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 2 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for Nexalin Technology, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| September 2, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
Tools for this story
Each opens in a new tab, filled in for Nexalin Technology, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.